Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors from the central anxious process, conolidine modulates alternate molecular targets. A Science Advancements review identified that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid pep... https://davidc702bys1.blogozz.com/profile